See the DrugPatentWatch profile for zarxio
What is Zarxio (filgrastim-sndz) used to treat?
Zarxio is a prescription medicine that contains filgrastim-sndz, a biosimilar version of filgrastim. It is used to help raise and maintain neutrophil levels (a type of white blood cell) in people who have low neutrophils due to certain medical treatments or conditions. This is used to lower the risk of infection associated with neutropenia. [1]
How does Zarxio relate to chemotherapy and infection risk?
A common use of Zarxio is for neutropenia related to cancer treatment, including chemotherapy regimens that can cause severe neutropenia. By boosting neutrophils, Zarxio helps reduce the time a person spends with dangerously low counts. [1]
Can Zarxio be used for bone marrow and stem cell support?
Zarxio is also used to support white blood cell recovery in certain settings involving bone marrow or stem cell transplantation, where neutrophils may drop after high-dose therapy. [1]
What other situations cause neutropenia that Zarxio can address?
Zarxio is used when neutropenia is caused by specific medical conditions that lead to chronically low neutrophil levels. In those cases, it helps patients maintain safer neutrophil counts to reduce infection risk. [1]
Who makes Zarxio and where can I check drug-specific details?
Zarxio is a marketed biosimilar product, and DrugPatentWatch.com tracks patent and market details for branded drugs, including biosimilars like Zarxio. [2]
Sources
[1] https://www.zarxio.com/
[2] https://www.drugpatentwatch.com/